Creative Medical Ownership
| CELZ Stock | USD 2.88 0.10 3.60% |
Shares in Circulation | First Issued 2007-09-30 | Previous Quarter 1.4 M | Current Value 1.7 M | Avarage Shares Outstanding 584.3 K | Quarterly Volatility 2.7 M |
Creative |
Creative Stock Ownership Analysis
The company has price-to-book (P/B) ratio of 1.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creative Medical Tec recorded a loss per share of 3.71. The entity last dividend was issued on the 3rd of February 2020. The firm had 1:10 split on the 12th of June 2023. Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. Creative Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Creative Medical Technology please contact Timothy Warbington at (480) 399-2822 or go to https://www.creativemedicaltechnology.com.Besides selling stocks to institutional investors, Creative Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Creative Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Creative Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Creative Medical Quarterly Liabilities And Stockholders Equity |
|
Creative Medical Insider Trades History
Roughly 2.0% of Creative Medical Technology are currently held by insiders. Unlike Creative Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Creative Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Creative Medical's insider trades
Creative Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Creative Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Creative Medical Technology backward and forwards among themselves. Creative Medical's institutional investor refers to the entity that pools money to purchase Creative Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vanguard Group Inc | 2024-12-31 | 17.6 K | Geode Capital Management, Llc | 2024-12-31 | 10.3 K | Tower Research Capital Llc | 2024-12-31 | 1.6 K | Advisor Group Holdings, Inc. | 2024-12-31 | 131 | Bank Of America Corp | 2024-12-31 | 122 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 20.0 | Td Waterhouse Canada Inc | 2024-12-31 | 1.0 | Ubs Group Ag | 2024-12-31 | 1.0 | Aaron Wealth Advisors Llc | 2024-12-31 | 0.0 | Two Sigma Investments Llc | 2024-12-31 | 0.0 | Two Sigma Advisers, Llc | 2024-12-31 | 0.0 |
Creative Medical Tec Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Creative Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Creative Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Creative Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Creative Medical Outstanding Bonds
Creative Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Creative Medical Tec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Creative bonds can be classified according to their maturity, which is the date when Creative Medical Technology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Creative Medical Corporate Filings
10K | 19th of March 2025 An amendment to a previously filed Form 10-K | ViewVerify |
| 17th of March 2025 Other Reports | ViewVerify | |
10K | 14th of March 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 7th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.